Learn more about the Cost of Goods aspect of cell and gene therapies: what is this cost comprised of and how can you reduce it?
关于作者
Division Head Quality Assurance at QbD Group
Dominiek leads the Quality Assurance division at QbD Group, helping life science companies build and maintain GxP-compliant quality management systems.
专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
Keep reading
Orphan strategy decisions go beyond incentives. Learn how regulatory definitions, evidence requirements, timing, and exclusivity across the EU, US, and UK shape early biotech development strategy.
阅读更多
Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
阅读更多
Explore how Environmental Risk Assessment (ERA) helps ensure medicines heal us without harming the planet, balancing healthcare advances with ecological preservation.
阅读更多